Last reviewed · How we verify

NCT06727708: Biocircuit

Comparison of Two BioCircuit Programs: Impact on Physical Fitness and Body Composition in Adults Aged 30-65

Recruiting now NA Last updated 11 December 2024
What this trial tests

NA trial testing Tone Your Body BioCircuit Program in Muscle Strength in 42 participants. Currently enrolling.

Timeline
31 October 2024
Primary endpoint
31 October 2025
31 October 2025

Quick facts

Lead sponsorUniversity of Graz
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment42
Start date31 October 2024
Primary completion31 October 2025
Estimated completion31 October 2025
Sites1 location across Austria

Drugs / interventions tested

Conditions studied

Sponsor

University of Graz

Who can join

Adults 30 to 65, any sex, with Muscle Strength or Body Composition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare the effects of two BioCircuit training programmes, 'Tone Your Body' and 'Boost Performance', on physical fitness and body composition in adults aged 30-65 years. Participants will be randomized to one of the two exercise programmes and will undergo a 12-week intervention with baseline and post-intervention measurements of fitness and body composition. The study aims to determine which programme is more effective in improving overall physical fitness, muscle mass and reducing body fat.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Muscle Strength

Currently open trials in the same condition.

Other University of Graz trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06727708.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing